Underdosing of unsp fibrinolysis-affecting drugs, subs

This code signifies that a patient is experiencing adverse effects or complications due to receiving an insufficient amount of an unspecified medication intended to dissolve blood clots (fibrinolysis-affecting drug). This underdosing is being addressed during a follow-up visit after the initial treatment or assessment.

Use this code when a patient presents for ongoing management of a condition exacerbated by, or directly resulting from, an inadequate dose of a fibrinolytic agent. This typically occurs in scenarios where the initial underdosing has already been identified and the patient is returning for further evaluation, treatment adjustments, or monitoring of related complications.

• Always assign an additional code for the specific adverse effect or complication resulting from the underdosing.
• Ensure documentation clearly indicates that the encounter is for follow-up care related to the underdosing, not the initial event.
• If the specific fibrinolysis-affecting drug is known, a more specific code from the T45.6 category should be used instead.